Danilo De Gregorio

Postdoctoral fellow in the Neurobiological Psychiatry Unit at McGill University

Data updated

Papers

5 publications

Trials

0 clinical trials

Links

Research Footprint

Danilo De Gregorio appears in 5 tracked papers (2016–2022), most studied alongside LSD, Psilocybin and DMT, across Depressive Disorders, Anxiety Disorders and Interpersonal Functioning & Social Connectedness.

Most-cited paper: Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms (222 citations).

Frequent co-authors: Gabriella Gobbi, Matthias Liechti and Friederike Holze.

Background & Research

Danilo De Gregorio is a researcher in psychiatry and neuropharmacology whose publications focus on classic psychedelics, especially LSD, and their effects on social behavior, synaptic plasticity, and neurotransmitter systems. He has collaborated extensively with Gabriella Gobbi’s group at McGill University on preclinical and translational studies of psychedelics in mental health. His work has been recognized by McGill, including an award for his LSD social-behavior paper.

Key Impact

He is a notable psychedelic psychiatry researcher whose work has helped define LSD’s mechanisms and its potential relevance to social behavior, autism spectrum disorder, and psychiatric treatment.

5

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

5 collaborators· click a node to visit their profile

Full network →

Affiliations

Institutions, companies, and organisations Danilo De Gregorio is associated with.